Paper6770263
A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds.
Brown JP. Mutat Res, 1980. Cited by 420 papers, by iCite.
Cite this record
ConductScience Library. A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds. Papers, record 6770263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6770263
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anthraquinones | Major topic |
| Flavonoids | Major topic |
| Mutagens | Major topic |
| Anti-Bacterial Agents | |
| Antioxidants | |
| Bacillus subtilis | |
| Carcinogens | |
| DNA | |
| Diet | |
| Food Preservatives | |
| Genetic Techniques | |
| Humans | |
| Plants | |
| Salmonella typhimurium | |
| Structure-Activity Relationship |
Source PubMed
Cited by75
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 420 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42742702 | Genotoxicity of anthraquinone dyes and dye intermediates: a comprehensive review. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/42742702 | PubMed |
| 38921356 | In Vitro Toxicity Assessment of Cortinarius sanguineus Anthraquinone Aglycone Extract. | J Fungi (Basel) | 2024 | https://conductscience.org/library/papers/38921356 | PubMed |
| 38058699 | Introducing a novel chemotherapeutic drug formulated with anthraflavic acid for treating human breast carcinoma and type 2 diabetes mellitus. | Arch Med Sci | 2023 | https://conductscience.org/library/papers/38058699 | PubMed |
| 37941972 | Medicinal Plants Used as an Alternative to Treat Gingivitis and Periodontitis. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/37941972 | PubMed |
| 37855943 | Antimicrobial Compounds in Wine. | Probiotics Antimicrob Proteins | 2024 | https://conductscience.org/library/papers/37855943 | PubMed |
| 36594062 | Elucidation of flavonoids from potent Iranian Scutellaria species against Influenza A (H1N1) virus. | Iran J Basic Med Sci | 2023 | https://conductscience.org/library/papers/36594062 | PubMed |
| 36354896 | Waterless Dyeing and In Vitro Toxicological Properties of Biocolorants from Cortinarius sanguineus. | J Fungi (Basel) | 2022 | https://conductscience.org/library/papers/36354896 | PubMed |
| 36249807 | Scutellaria baicalensis Georgi regulates REV-ERBα/BMAL1 to protect against skin aging in mice. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36249807 | PubMed |
| 35892127 | Identification of Natural Product Sulfuretin Derivatives as Inhibitors for the Endoplasmic Reticulum Redox Protein ERO1α. | ACS Bio Med Chem Au | 2022 | https://conductscience.org/library/papers/35892127 | PubMed |
| 35178359 | Quercetin Arrests in G2 phase, Upregulates INXS LncRNA and Downregulates UCA1 LncRNA in MCF-7 Cells. | Int J Mol Cell Med | 2021 | https://conductscience.org/library/papers/35178359 | PubMed |
| 34685098 | Nanotechnology Innovations to Enhance the Therapeutic Efficacy of Quercetin. | Nanomaterials (Basel) | 2021 | https://conductscience.org/library/papers/34685098 | PubMed |
| 33801847 | Baicalin Represses Type Three Secretion System of Pseudomonas aeruginosa through PQS System. | Molecules | 2021 | https://conductscience.org/library/papers/33801847 | PubMed |
| 33271809 | Biophysical Characterization and Anticancer Activities of Photosensitive Phytoanthraquinones Represented by Hypericin and Its Model Compounds. | Molecules | 2020 | https://conductscience.org/library/papers/33271809 | PubMed |
| 32947880 | The Dioscorea Genus (Yam)-An Appraisal of Nutritional and Therapeutic Potentials. | Foods | 2020 | https://conductscience.org/library/papers/32947880 | PubMed |
| 32636851 | Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19). | Front Immunol | 2020 | https://conductscience.org/library/papers/32636851 | PubMed |
| 32443886 | Examining Safety of Biocolourants from Fungal and Plant Sources-Examples from Cortinarius and Tapinella, Salix and Tanacetum spp. and Dyed Woollen Fabrics. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/32443886 | PubMed |
| 32213958 | Virulence-Inhibiting Herbal Compound Falcarindiol Significantly Reduced Mortality in Mice Infected with Pseudomonas aeruginosa. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/32213958 | PubMed |
| 31523708 | Excited state intramolecular proton transfer in hydroxyanthraquinones: Toward predicting fading of organic red colorants in art. | Sci Adv | 2019 | https://conductscience.org/library/papers/31523708 | PubMed |
| 30063944 | Formation and biological targets of botanical o-quinones. | Food Chem Toxicol | 2018 | https://conductscience.org/library/papers/30063944 | PubMed |
| 29854622 | What is the meaning of 'A compound is carcinogenic'? | Toxicol Rep | 2018 | https://conductscience.org/library/papers/29854622 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6770263
GET https://conductscience.org/api/papers/v1/6770263/cited_by?page=2